Delivery Order SPE2DR25D1109-SPE2DR26FFH4W
- Not listed
- The Defense Logistics Agency awarded a $3,556.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 14, 2025, with completion targeted for November 17, 2025. This is a non-set-aside award issued as a delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $70,061.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on November 4, 2025, with an ultimate completion date of November 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's Corporate Office, headquartered in Conshohocken, Pennsylvania, where the products will...
- The Defense Logistics Agency has awarded a delivery order valued at $8,161.26 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units). The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to this major pharmaceutical distributor. The award was made on November 4, 2025, with an ultimate completion date of November 5, 2025, and the place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,330.33 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on November 12, 2025, with completion scheduled for November 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $3,258.15 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,235.76 for NURTEC ODT 75 MG tablets (8-count) on December 2, 2025, with completion scheduled for December 3, 2025. This competitive, non-set-aside award reflects a firm fixed price contract for pharmaceutical delivery to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $33,819.84 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,753.37 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-pack units) with an ultimate completion date of October 31, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a $14,575.89 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on November 24, 2025, with completion expected by November 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH4WDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,302.77 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 5, 2025, with completion scheduled for December 8, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award under open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor contract enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The underlying IDC covers a broad range of medications across multiple therapeutic domains, positioning AmerisourceBergen as a critical pharmaceutical supplier for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 12/4/25 |